meet other global citizens who care about the same issues you do. keep updated on what they're doing to change the world. . .
why novartis� landmark cancer drug approval is great news for bluebird http://lm360.us/Menezes-mother-of-Welborn-from-Lebrade?Clientnei=109
in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance. .